PYC and Aileron Therapeutics seem to be working in parallel. I...

PYC and Aileron Therapeutics seem to be working in parallel.

I would think they would be considered competitors.

They both have cell penetrating peptides.

PYC in Perth Australia, Aileron in Cambridge Massachusetts.

They are both very small peptide companies. Aileron had in June 2009, 23 staff.

In June 2009, 4 global pharmas GlaxoSmithKline,Novartis,Roche and Eli Lilly joined a consortium to pump $40mill into Aileron.

Then in August 2010 Roche slips $1.1Bil into Aileron's bra.

Could Aileron's performance in the last 15mths be a gauge of PYCs next 12mths.

They are competitors, but surely there is room for two in this world of ours.

Roche has signed with PYC since they pumped the initial money into the consortium for Aileron. So they are testing the different brands of peptides.

I've shown what Aileron has achieved in the past 12mths so you can see what is possible for PYCs next 12mths.

In the 'Rights Prospectus', Dougy presented us with an opportunity to participate in a potentially transformational period for PYC.

All I can say is, bring on the next 12mths.